No, Sky-High Drug Prices Aren’t Funding Crucial New Medical Research
No, Sky-High Drug Prices Aren’t Funding Crucial New Medical Research
jacobin.com No, Sky-High Drug Prices Aren’t Funding Crucial New Medical Research
Last month, the Biden administration announced it would allow Medicare to negotiate drug prices, prompting right-wing hysteria about price controls. Yet Biden's plans don’t go far enough: the state should fund R&D to further cut costs.
![No, Sky-High Drug Prices Aren’t Funding Crucial New Medical Research](https://hexbear.net/pictrs/image/dd550aed-d563-4e78-b635-9338a7578166.jpeg?format=webp&thumbnail=256)
0
comments